Mönning
Tim Mönning, Bremen DE
Patent application number | Description | Published |
---|---|---|
20100236704 | APPARATUS AND METHOD FOR AUTOMATICALLY FABRICATING TAPE WITH THREADS FOR VISUALIZATION OF AIR STREAMS ON AERODYNAMIC SURFACES - Apparatus and method for visualizing air stream by little threads on aerodynamic surfaces such that strips of adhesive tape populated with threads are automatically fabricated. | 09-23-2010 |
Tim Mönning, Bremen DE
Patent application number | Description | Published |
---|---|---|
20100236704 | APPARATUS AND METHOD FOR AUTOMATICALLY FABRICATING TAPE WITH THREADS FOR VISUALIZATION OF AIR STREAMS ON AERODYNAMIC SURFACES - Apparatus and method for visualizing air stream by little threads on aerodynamic surfaces such that strips of adhesive tape populated with threads are automatically fabricated. | 09-23-2010 |
Ursula Mönning, Woltersdorf DE
Patent application number | Description | Published |
---|---|---|
20110250135 | Piperazine Derivatives for Binding and Imaging Amyloid Plaques and Their Use - The invention relates to compounds of formula I, their synthesis and their use, in particular for detecting amyloid deposits in a patient. | 10-13-2011 |
20120237446 | Compounds for binding and imaging amyloid plaques and their use - The present invention relates to novel compounds (3-aminopropen-1-ones) useful for binding and imaging beta amyloid deposits and their use in detecting or treating Alzheimer's disease and amyloidosis. | 09-20-2012 |
20130317004 | AMINOALCOHOL SUBSTITUTED 2,3-DIHYDROIMIDAZO[1,2-C]QUINAZOLINE DERIVATIVES USEFUL FOR TREATING HYPER-PROLIFERATIVE DISORDERS AND DISEASES ASSOCIATED WITH ANGIOGENESIS - This invention relates to novel 2,3-dihydroimidazo[1,2-c]quinazoline compounds, pharmaceutical compositions containing such compounds and the use of those compounds or compositions for phosphotidylinositol-3-kinase (PI3K) inhibition and treating diseases associated with phosphotidylinositol-3-kinase (PI3K) activity, in particular treating hyper-proliferative and/or angiogenesis disorders, as a sole agent or in combination with other active ingredients. | 11-28-2013 |